StreetAccount Sector Summary - Healthcare Post-Market
StreetAccount Summary - US Pre-market trading update
StreetAccount Sector Summary - Healthcare Pre-Market
StreetAccount Summary - US Pre-market trading
Fresenius Medical Care delivers 27% earnings growth in 2025 and reaches upper end of its financial outlook; margin within 2025 mid-term target band
Street Takeaways - Fresenius Medical Care Q4 beats but shares fall on soft 2026 revenue guidance and cautious medium-term outlook (€39.03, -2.36)
StreetAccount Summary - Trading higher/lower: EU mid-morning
StreetAccount Summary - European pre-market trading update
StreetAccount Metrics Recap - Fresenius Medical Care Q4 Earnings (€41.39, 0.00)
Fresenius Medical Care reports Q4 operating income excl. special items €705M vs consensus €633M (€41.39, 0.00)
Powered by FactSet Research Systems Inc.